Additionally, we found that high VCPIP1 expression is associated with poor prognosis not only in pancreatic cancer (PAAD) (Disease-free survival, Fig. 1D; Overall survival, Fig. S1B) but also in multiple other cancers (Fig. S1C–G), including lung adenocarcinoma (LUAD), kidney renal papillary cell carcinoma (KIRP), cervical squamous cell carcinoma (CESC), uterine corpus endometrial carcinoma (UCEC), and thyroid carcinoma (THCA). Here, VCPIP1 is linked to pancreatic neoplasm.